Bristol-Myers Squibb Company
Government Contracts & Awards
No recent government contracts or awards found.
Proprietary Tech & Patents
CANCER IMMUNOTHERAPY BY DISRUPTING PD-1/PD-L1 SIGNALING
Form D Funding
No recent SEC Form D filings found.
Market Intelligence & News
Bristol-Myers Squibb (BMY) Bets $2.3 Billion on Texas While Eli Lilly (LLY) Wins in the UK
Drugmaker Bristol-Myers Squibb Company (NYSE:BMY) is putting real money behind its confidence in American manufacturing. On August 10, the company said it will spend about $2.3 billion on a new plant in Houston, part of a larger $40 billion U.S. investment pledge. On the very same day, British regulators cleared Eli Lilly and Company (NYSE:LLY)’s […]
AstraZeneca Vs. Bristol-Myers Squibb: Who's The Better Bargain For Investors?
Rumors of an AstraZeneca PLC-Bristol-Myers Squibb Company merger are cooling. Click here for risks and drug portfolio insights on BMY and AZN stock.
Why Is Bristol-Myers Squibb Stock Surging Monday?
Bristol Myers Squibb and AstraZeneca in talks for a $400B mega-merger, potentially creating the world's 4th-largest drugmaker.
Bristol-Myers Squibb: Why I'm Still Bullish After Q2
Bristol-Myers Squibb Company hits a 52-week high on Q2 results, EPS guidance raise, and key drugsâ momentum. Read why BMY stock is a buy.
Congressional Trades in $BMY
Insider Trades (Form 4)
Massacesi Cristian
Short Bartie Wendy
Holzer Phil M
Massacesi Cristian
Gallman Cari
Samuels Theodore R. II
Rice Derica W
YALE PHYLLIS R
Key People
No individuals linked to this entity yet.
Political Giving
$226,500 given to 47 candidates across 127 disclosed contributions (FEC Schedule A).
Suzan K. DelBene
Katherine M. Clark
Bradley S. Schneider
Adrian Smith
Darin McKay LaHood
Diana Harshbarger
Scott H. Peters
Thomas H. Kean
Linda T. Sanchez
James E Hon Banks
Greg Steube
Terri A. Sewell
Carol Devine Miller
Josh Gottheimer
James Comer
Rudy C. Yakym
Kevin Hern
Chris Coons
Earl Leroy Carter
August Lee Pfluger
+ 27 more recipients not shown.
Factual Connections
Connections to other companies, executives, and politicians — sourced from disclosed trades, shared officers/directors, and public filings — are a Pro/Alpha feature.
Upgrade to Pro